Grant: Idea to Innovation
University of Toronto
$123,340.00
Phase I: High throughput fabrication of fractal cell culture substrates
FY 2022-23
Summary
Currently, there are no cell culture techniques that enable high fidelity cultivation of the key kidney cells: podocytes. Monolayer culture fails to recapitulate their branching phenotype. We have developed a completely new approach: by faithfully recreating fractal topographical cues of the native kidney glomerulus on cell culture substrates, we microengineered an environment where podocytes exhibit their branching morphology and gene expression similar to the podocytes in vivo. Such improved cell culture was superior in new compound testing and coronavirus infection studies compared to the conventional monolayers. The main goal of this proposal is to develop a high throughput manufacturing process for production of commercial well plates with fractal topographical cues, from the current manual process that takes >20hr to produce one 2x2cm2 substrate, to a process that takes 15min per plate. In Aim 1, we will scale-up production by hot embossing and injection molding to create commercial 24- and 96-well plates. In Aim 2, we will develop sterilization protocol for these plates and in Aim 3, we will validate their biocompatibility. To reach the desired production throughput and create non-absorbent devices, we need to overcome the main engineering challenge of scaling from polydimethylsiloxane lab prototype inserts to non-absorbent thermoplastic elastomer laminated on glass. Our main customers will be pharmaceutical companies, e.g. Regeneron that filled an order form, and academic laboratories who have a need for high fidelity culture of podocytes. Our collaborators, Drs. Quaggin, Barua and Rogers, are leading kidney researchers, eager to test the new plates for podocyte cultivation in their laboratories. The new manufacturing process can also be used to fabricate fractal plates for other cells e.g. adipocytes and lung cells. Our preferred model is licensing the plates to an existing established company that manufactures and distributes innovative tools for life science research, such as companies that provided support letters-Stem Cell Technologies and uFluidix. The plates will also enable discovery of new compounds for kidney disease, through a new start-up that our team members will work on.
Program
Idea to Innovation
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
567631-2022
Name nom
Radisic, Milica M
Department département
Biomedical Engineering, Institute of (BME)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
123340
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
508
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Polymers, rubber and plastics
Area of application fr
Polymères, caoutchouc et plastiques
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Installment
inst:1
Partie
1
Nb partie
1
Application title
Phase I: High throughput fabrication of fractal cell culture substrates
Application summary
Currently, there are no cell culture techniques that enable high fidelity cultivation of the key kidney cells: podocytes. Monolayer culture fails to recapitulate their branching phenotype. We have developed a completely new approach: by faithfully recreating fractal topographical cues of the native kidney glomerulus on cell culture substrates, we microengineered an environment where podocytes exhibit their branching morphology and gene expression similar to the podocytes in vivo. Such improved cell culture was superior in new compound testing and coronavirus infection studies compared to the conventional monolayers. The main goal of this proposal is to develop a high throughput manufacturing process for production of commercial well plates with fractal topographical cues, from the current manual process that takes >20hr to produce one 2x2cm2 substrate, to a process that takes 15min per plate. In Aim 1, we will scale-up production by hot embossing and injection molding to create commercial 24- and 96-well plates. In Aim 2, we will develop sterilization protocol for these plates and in Aim 3, we will validate their biocompatibility. To reach the desired production throughput and create non-absorbent devices, we need to overcome the main engineering challenge of scaling from polydimethylsiloxane lab prototype inserts to non-absorbent thermoplastic elastomer laminated on glass. Our main customers will be pharmaceutical companies, e.g. Regeneron that filled an order form, and academic laboratories who have a need for high fidelity culture of podocytes. Our collaborators, Drs. Quaggin, Barua and Rogers, are leading kidney researchers, eager to test the new plates for podocyte cultivation in their laboratories. The new manufacturing process can also be used to fabricate fractal plates for other cells e.g. adipocytes and lung cells. Our preferred model is licensing the plates to an existing established company that manufactures and distributes innovative tools for life science research, such as companies that provided support letters-Stem Cell Technologies and uFluidix. The plates will also enable discovery of new compounds for kidney disease, through a new start-up that our team members will work on.